About Endosee
Endosee is a Healthcare company based in Los Altos (United States) founded in 2011, and was acquired by CooperSurgical in October 2014. Disposable office-based hysteroscopy systems are developed for gynecological procedures. It operates on a Direct-to-Consumer (D2C) model. Endosee has raised $4.37 million across 3 funding rounds from investors including CooperSurgical. Endosee offers products and services including Endosee Advance and Disposable Retrieval Snares. Its focus areas include Medical Devices and Diagnostic Equipment. Its legal entity is CooperSurgical, Inc. Its competitors include Gynesonics, Channel Medsystems and Minerva Surgical; 3 of its 3 listed competitors have raised funding.
Company details
Endosee, under CooperSurgical, Inc., is engaged in the development and distribution of diagnostic hysteroscopy devices. The company specializes in endometrial imaging solutions through products like Endosee Advance, which enables direct visualization for in-office exams. Additional offerings include disposable retrieval snares for polyp removal. The solutions are designed to enhance patient care by reducing the need for operating room visits and improving workflow efficiency in medical practices. The primary sector served is healthcare, with a focus on gynecological diagnostics.
- Headquarters Los Altos, United States
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website endosee.com
- Acquired by CooperSurgical (Oct 2014)
- Legal Name Coopersurgical, Inc.
- Total Equity Funding$4.37M (USD)
in 3 rounds
- Latest Funding Round$1.81M (USD), Seed
Jun 2014
- Investors
- Acquired byCooperSurgical
(Oct 2014)
Products & Services of Endosee
Endosee offers a comprehensive portfolio of products and services, including Endosee Advance and Disposable Retrieval Snares.
Direct visualization system for endometrial imaging is provided.
Single-use tools for polyp removal are offered here.
Funding Insights of Endosee
Endosee has successfully raised a total of $4.37M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $1.81 million completed in June 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4.37M
- Total Rounds 3
- Last Round Seed — $1.81M
- First Round $887,672
(Nov 2011)
All 3 funding rounds of Endosee with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2014 | $1.81M | Seed | – | – | – |
| Feb 2013 | $1.68M | Seed | – | – | – |
| Nov 2011 | $887,672 | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in Endosee
Endosee has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include CooperSurgical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Offers medical devices for fertility, contraception, and women's health care globally. | 1990 | coopersurgical.com | Trumbull, United States |
Investor details for Endosee
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Endosee
4 dated milestones of Endosee across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Endosee is founded.
- Funding First funding round of $888K.
- Funding Latest funding round, Seed, of $1.8M.
- Exit Acquired by CooperSurgical.
Competitors of Endosee
Endosee has 3 listed competitors in our database, 3 of them funded. They include Gynesonics, Channel Medsystems and Minerva Surgical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gynesonics.com | 2005 | Redwood, United States | $282.54M | 92 | A minimally invasive ablation system for uterine fibroids is developed. | |
| channelmedsystems.com | 2009 | San Francisco, United States | $47.67M | 37 | Cryothermic technology for endometrial ablation to control heavy bleeding | |
| minervasurgical.com | 2008 | Redwood, United States | $135.1M | 155 | Minerva Surgical is focused on uterine health solutions. |
Detailed competitors of Endosee
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Endosee
The website of Endosee (endosee.com) receives about 3.4K visits a month.
- Monthly visits3.4K
▲ 65.5% vs previous month
Top companies in Women's Health & Fertility
3 companies that operate in the same segment as Endosee (Women's Health & Fertility) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of cell-free DNA testing for oncology, women’s health, and organ health | 2004 | Redwood City, California, United States | USD 152.1 M | USD 2.31 B | 4,430 | |
Therapeutics for women's healthcare are developed and offered. | 1997 | Princeton, New Jersey, United States | USD 123.06 M | USD 19.59 M | ||
Provider of cell-free cancer liquid biopsy test | 2015 | San Francisco, California, United States | USD 388.62 M | 861 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Endosee
Endosee was founded in 2011.
Endosee is headquartered in Los Altos, United States. It is registered at Los Altos, California, United States.
Endosee is a funded company, having raised a total of $4.37M across 3 funding rounds to date. The company's 1st funding round was a Seed of $887.67K, raised on Nov 2011.
Endosee, under CooperSurgical, Inc., is engaged in the development and distribution of diagnostic hysteroscopy devices. The company specializes in endometrial imaging solutions through products like Endosee Advance, which enables direct visualization for in-office exams. Additional offerings include disposable retrieval snares for polyp removal. The solutions are designed to enhance patient care by reducing the need for operating room visits and improving workflow efficiency in medical practices. The primary sector served is healthcare, with a focus on gynecological diagnostics.
Endosee's top competitors include Gynesonics, Channel Medsystems and Minerva Surgical.
Endosee offers Endosee Advance and Disposable Retrieval Snares.
Endosee has 1 investor. Key investors include CooperSurgical.
Endosee operates through Coopersurgical, Inc..
Yes. Endosee was acquired by CooperSurgical in October 2014.